Stockscreener 앱 받기
35.88
2.78%
0.97
시간 외 거래:
35.88
전일 마감가:
$34.91
열려 있는:
$35.53
하루 거래량:
310.36K
Relative Volume:
0.61
시가총액:
$1.78B
수익:
$3.53B
순이익/손실:
$30.99M
주가수익비율:
58.49
EPS:
0.6134
순현금흐름:
$154.99M
1주 성능:
-1.35%
1개월 성능:
-6.97%
6개월 성능:
+43.23%
1년 성능:
+29.20%
1일 변동 폭
$35.11
$36.39
1주일 범위
$34.46
$36.83
52주 변동 폭
$18.08
$51.60
Astrana Health Inc Stock (ASTH) Company Profile
명칭
Astrana Health Inc
전화
(626) 282-0288
주소
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH vs HCA, THC, FMS, EHC, DVA
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ASTH
Astrana Health Inc
|
35.88 | 1.80B | 3.53B | 30.99M | 154.99M | 0.6134 |
HCA
Hca Healthcare Inc
|
426.69 | 94.31B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
258.62 | 20.91B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
22.25 | 12.08B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
119.80 | 12.18B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
178.69 | 11.39B | 13.84B | 1.10B | 1.49B | 10.42 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-12 | 개시 | Needham | Buy |
| 2025-04-01 | 개시 | Barclays | Equal Weight |
| 2024-10-14 | 개시 | TD Cowen | Buy |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2024-07-11 | 업그레이드 | Truist | Hold → Buy |
| 2024-05-30 | 개시 | Robert W. Baird | Outperform |
| 2024-02-26 | 개시 | Jefferies | Buy |
| 2024-02-22 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-01-24 | 개시 | Stifel | Buy |
| 2023-12-22 | 개시 | Truist | Hold |
| 2023-10-17 | 개시 | BTIG Research | Buy |
| 2023-04-12 | 개시 | BofA Securities | Neutral |
| 2022-12-19 | 개시 | Lake Street | Buy |
| 2022-09-21 | 개시 | William Blair | Outperform |
| 2022-01-11 | 재개 | Colliers Securities | Buy |
| 2021-08-12 | 개시 | Barclays | Equal Weight |
모두보기
Astrana Health Inc 주식(ASTH)의 최신 뉴스
Investigation launched into Astrana Health over alleged securities fraud after stock drops 9%. - Pluang
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH - PR Newswire
Freedom Capital Markets maintains Buy rating on Astrana Health, $50 price target - TradingView
Astrana Health Inc. (ASTH) Stock Forecasts - Yahoo Finance
Healthcare Technology for Providers Stocks Q2 In Review: Astrana Health (NASDAQ:ASTH) Vs Peers - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages Astrana Health, Inc - The National Law Review
Astrana Health Hack: SEC Filing Lands Sept. 22 [2026] - shattered.io
Astrana Health Inc. Earnings and Revenue – HAN:3AM - TradingView
Revenue per share of Astrana Health Inc. – HAN:3AM - TradingView
Astrana Health Inc. Statistics – HAN:3AM - TradingView
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc. - GlobeNewswire Inc.
Astrana Health Inc. (ASTH) Slips 3.41% to $35.13 as Shares Test Lower SupportRatio Spread Trade - siam.in
ASTH Investors Have Opportunity to Join Astrana Health, Inc. Fraud Investigation with SBS Law - Business Wire
Astrana Health Reveals Spoofing Attack Targeting Private Data - Law360
Astrana Health Inc (ASTH) Stock Up 5.6% and Still Undervalued -- GF Score: 88/100 - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Is Investigating Astrana Health, Inc. (ASTH) And Encourages Investors to Connect - accessnewswire.com
Astrana Health faces securities fraud probe aft... - Pluang
Apollo Medical Holdings Inc (3AM.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bronstein, Gewirtz & Grossman, LLC Is Investigating Astrana Health, Inc. (ASTH) And Encourages Stockholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Astrana Healt - The National Law Review
Astrana buys Prospect's managed care arm for $708M out of bankruptcy - Dealroom
Astrana Health, Inc. (ASTH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Astrana Health, Inc. (ASTH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Why Astrana Health (ASTH) Shares Are Trading Lower Today - Yahoo Finance
Astrana Health Q3 Results: Sales guide $1.000B-$1.030B vs $1.021B est - scanx.trade
Astrana Health Latest Results: Sales guidance affirmed at $3.8B-$4.1B - scanx.trade
Astrana Health FY26 Results: Sales guidance affirmed at $3.800B-$4.100B - scanx.trade
Astrana Health, Inc. - reuters.com
Astrana Health Reports Material Cyberattack; Shares Fall Pre-Bell - marketscreener.com
Astrana is latest U.S. healthcare company to face acyberattack - TradingView
Material cyber incident at Astrana Health (NASDAQ: ASTH); data review underway - Stock Titan
Astrana Health (ASTH) Stock May Be Fully Priced As Shares Fell 67% - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Astrana Health, Inc. (ASTH) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Lowey Dannenberg, P.C. is Investigating Astrana Health, - GlobeNewswire
Astrana Health Inc. (ASTH) Stock Analysis: A Promising 54% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Lowey Dannenberg probes Astrana Health after short-seller report - scanx.trade
M&A AwardsDEAL OF THE YEAR$500 MILLION – $1 BILLION HONOREE: Astrana Health acquires Prospect Medical Holdings - Los Angeles Business Journal
Astrana Health: Strong Execution, Still No Re-Rating (NASDAQ:ASTH) - Seeking Alpha
A Look at Astrana Health Inc (ASTH) After 9.0% Decline -- GF Val - GuruFocus
Astrana Health stock tumbles after short report - Investing.com
Astrana Health stock tumbles after short report By Investing.com - Investing.com Canada
Astrana Health Shares Fall After GlassHouse Research Publishes Short-Seller Report - Moomoo
Astrana Health falls amid short call from GlassHouse Research - TradingView
Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know - Yahoo Finance
Form 8K Astrana Health Inc For: 15 September By Investing.com - Investing.com India
Astrana Health updates corporate presentation, reiterates FY2026 guidance and $267.5M adj. EBITDA midpoint - TradingView
Oppenheimer Initiates Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $53 - Moomoo
Oppenheimer Initiates Astrana Health at Outperform With $53 Price Target - marketscreener.com
2 Cash-Producing Stocks with Competitive Advantages and 1 We Turn Down - The Globe and Mail
ETFs Investing in Astrana Health Inc. Stocks - TradingView
Astrana Health Inc (ASTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Astrana Health Inc 주식 (ASTH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Sim Brandon | CEO and President |
Feb 02 '26 |
Option Exercise |
23.24 |
21,334 |
495,802 |
1,045,329 |
| Schmidt David | Director |
Jan 13 '26 |
Option Exercise |
5.79 |
20,000 |
115,800 |
35,763 |
| Lam Thomas S. | Director |
Dec 08 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
459,122 |
| Sim Kenneth T. | Executive Chairman |
Nov 10 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
639,407 |
| Kitayama Mitchell W | Director |
Nov 07 '25 |
Option Exercise |
18.20 |
12,000 |
218,400 |
27,846 |
| Mazdyasni Matthew | Director |
Nov 10 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
34,763 |
| Marsh Linda | Director |
Nov 03 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
103,641 |
1.94%
자본화:
|
볼륨(24시간):